Back to Aberdeen Group plc Aberdeen Group plc

ALLOALLO
7 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in ALLOGENE THERAPEUTICS INC

Aberdeen Group plc holds 5M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $10.4M as of 2026-Q2. The position was increased (+242.1% shares). ALLO represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$10.4M

Current Shares

5M

Total Value Change

+$9.6M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5M
+242.1%
$10.4M0.0%$2.08
45
2026-Q1
Decreased
1.5M
-29.9%
$3.6M0.0%$2.53
0
2025-Q4
Increased
2.1M
+31.9%
$2.9M0.0%$1.31
34
2025-Q3
Increased
1.6M
+82.5%
$2M0.0%$1.27
40
2025-Q2
Unchanged
867,250
0.0%
$979,9930.0%$1.18
0
2025-Q1
Increased
867,250
+138.0%
$1.3M0.0%$1.55
41
2024-Q4
New
364,382
-
$776,1340.0%$2.10
34

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used